10 X Genomics Inc (TXG) 재무 분석
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues | 0.24%150.67 | 151.04 | 150.84 | 166.03 | 149.00 |
| Cost Of Revenue | 2.07%37.74 | 38.54 | 44.67 | 52.99 | 48.70 |
| Gross Profit | 0.38%112.93 | 112.50 | 106.18 | 113.05 | 100.31 |
2.32%128.98 | 132.05 | 123.22 | 132.59 | 132.55 | |
| Selling, General, and Administrative | 3.31%76.06 | 78.66 | 66.38 | 76.62 | 75.36 |
| Operating Income/Loss | 17.89%-16.06 | -19.56 | -17.05 | -19.54 | -32.24 |
| Nonoperating Income/Loss | 365.82%-2.42 | 0.91 | 4.20 | 4.35 | 4.04 |
| Income/Loss From Continuing Operations Before Tax | 0.91%-18.48 | -18.65 | -12.85 | -15.19 | -28.21 |
| Income Tax Expense/Benefit, Deferred | - | - | - | - | - |
| Income Tax Expense/Benefit | 232.91%0.95 | -0.71 | 0.62 | 1.06 | -0.73 |
8.33%-19.43 | -17.93 | -13.47 | -16.25 | -27.47 | |
| Attributable To Parent | 8.33%-19.43 | -17.93 | -13.47 | -16.25 | -27.47 |
| Basic Average Shares | 0.63%130.81 | 129.98 | 128.29 | 0.78 | 125.50 |
| Diluted Average Shares | 0.63%130.81 | 129.98 | 128.29 | 0.78 | 125.50 |
| Basic Earnings Per Share | 7.14%-0.15 | -0.14 | -0.10 | -0.13 | -0.22 |
| Diluted Earnings Per Share | 7.14%-0.15 | -0.14 | -0.10 | -0.13 | -0.22 |